These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16183392)

  • 1. Tissue dosimetry, metabolism and excretion of pentavalent and trivalent monomethylated arsenic in mice after oral administration.
    Hughes MF; Devesa V; Adair BM; Styblo M; Kenyon EM; Thomas DJ
    Toxicol Appl Pharmacol; 2005 Oct; 208(2):186-97. PubMed ID: 16183392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration.
    Hughes MF; Devesa V; Adair BM; Conklin SD; Creed JT; Styblo M; Kenyon EM; Thomas DJ
    Toxicol Appl Pharmacol; 2008 Feb; 227(1):26-35. PubMed ID: 18036629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration.
    Hughes MF; Kenyon EM
    J Toxicol Environ Health A; 1998 Jan; 53(2):95-112. PubMed ID: 9444314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate.
    Kenyon EM; Del Razo LM; Hughes MF
    Toxicol Sci; 2005 May; 85(1):468-75. PubMed ID: 15703264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
    Kenyon EM; Hughes MF; Adair BM; Highfill JH; Crecelius EA; Clewell HJ; Yager JW
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):448-55. PubMed ID: 18706920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Wang Z; Zhou J; Lu X; Gong Z; Le XC
    Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
    Suzuki KT; Katagiri A; Sakuma Y; Ogra Y; Ohmichi M
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):336-44. PubMed ID: 15276413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine.
    Le XC; Ma M; Cullen WR; Aposhian HV; Lu X; Zheng B
    Environ Health Perspect; 2000 Nov; 108(11):1015-8. PubMed ID: 11102289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of arsenic metabolic complex excreted in human urine after administration of sodium 2,3-dimercapto-1-propane sulfonate.
    Gong Z; Jiang G; Cullen WR; Aposhian HV; Le XC
    Chem Res Toxicol; 2002 Oct; 15(10):1318-23. PubMed ID: 12387631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of endogenous hydrogen peroxide and glutathione on the stability of arsenic metabolites in rat bile.
    Kobayashi Y; Hirano S
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):33-40. PubMed ID: 18619986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and speciation of arsenic after intravenous administration of monomethylmonothioarsonic acid in rats.
    Naranmandura H; Bu N; Suzuki KT; Lou Y; Ogra Y
    Chemosphere; 2010 Sep; 81(2):206-13. PubMed ID: 20594576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment.
    Cohen SM; Arnold LL; Eldan M; Lewis AS; Beck BD
    Crit Rev Toxicol; 2006 Feb; 36(2):99-133. PubMed ID: 16736939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
    Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of arsenic metabolites after long-term oral administration of various arsenic compounds to rats.
    Yoshida K; Inoue Y; Kuroda K; Chen H; Wanibuchi H; Fukushima S; Endo G
    J Toxicol Environ Health A; 1998 Jun; 54(3):179-92. PubMed ID: 9643871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speciation of arsenic in biological samples.
    Mandal BK; Ogra Y; Anzai K; Suzuki KT
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):307-18. PubMed ID: 15276410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate.
    Hughes MF; Kenyon EM; Edwards BC; Mitchell CT; Razo LM; Thomas DJ
    Toxicol Appl Pharmacol; 2003 Sep; 191(3):202-10. PubMed ID: 13678653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of arsenic biotransformation.
    Vahter M
    Toxicology; 2002 Dec; 181-182():211-7. PubMed ID: 12505313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the alkali labile sites, reactive oxygen species and antioxidants in DNA damage induced by methylated trivalent metabolites of inorganic arsenic.
    Soto-Reyes E; Del Razo LM; Valverde M; Rojas E
    Biometals; 2005 Oct; 18(5):493-506. PubMed ID: 16333750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells.
    Dopp E; Hartmann LM; von Recklinghausen U; Florea AM; Rabieh S; Zimmermann U; Shokouhi B; Yadav S; Hirner AV; Rettenmeier AW
    Toxicol Sci; 2005 Sep; 87(1):46-56. PubMed ID: 15947026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
    Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.